Page 260 - Read Online
P. 260

Page 14 of 23                         Parsons et al. J Cancer Metastasis Treat 2018;4:19  I  http://dx.doi.org/10.20517/2394-4722.2018.11

               unclear as to how BORG modulates TRIM28 binding to specific chromatin regions that in turn modulates
               a metastatic phenotype. One assumption is that specific sequence regions of BORG, outside the identified
               TRIM28 binding sequence, interacts with TRIM28 or additional TRIM domain-containing TFs through
               stacking interactions. These lncRNA structure-based interactions, mediate recruitment of the TRIM28
               transcriptional protein complex to the proximal promoters of genes such as Cdkn1a and Gadd45a. BORG
               also confers a unique transcriptional signature that is enriched for KRAS signaling, as compared to non-
               metastatic D2.OR breast cancer cells. Further studies elucidating the role of BORG in human breast cancer
               cells, as well as the regulatory role within the metastatic process, are warranted.


               Prostate cancer associated transcript 1
               Through genome wide RNA sequencing experiments, Prensner et al.  identified prostate cancer associated
                                                                         [183]
               transcript 1 (PCAT1) as a lncRNA highly upregulated in metastatic prostate cancer samples, as well as those
               considered high grade (i.e., stage II-IV). Upon knockdown of PCAT1 in prostate cancer cell lines, Prensner et al.
                                                                                                        [183]
               identified 370 genes expressed differentially, many of which were associated with cell-cycle progression and
               mitosis, as well as cytoskeleton and microtubule regulation. Knockdown studies indicated that loss of PCAT1
               resulted in an approximate 25% reduction in cellular proliferation, though the mechanism by which PCAT1
               promotes an invasive phenotype is still unclear. One possibility may be due to the involvement of PCAT1
               in the homologous recombination (HR) repair pathway. One can surmise, for instance, that as epithelial
               progenitor cells proliferate, the acquisition of successive mutations within the genome across daughter
               generations provides an opportunity for such cells to undergo a process such as EMT . Interestingly, PCAT1
                                                                                      [12]
               is inversely correlated with BRCA2 expression in LNCaP cells, while the knockdown of PCAT1 resulted
               in the upregulation of BRCA2, a crucial component of the DNA repair pathway [184,185] . Moreover, PCAT1
               overexpression alters the  formation of  RAD51 and  ɣ-H2aX foci  after  radiation-induced DNA  damage,
               while naturally occurring polymorphisms within the genome, such as rs7463708, can promote an enhanced
               proliferative and migratory state within prostate cancer cell lines . Therefore, it is entirely plausible that the
                                                                     [186]
               reduction in chromosome stability via enhanced PCAT1 activity supports not only a pro-tumorigenic state,
               but a pro-metastatic phenotype as well. Separating these two distinct yet equally important mechanisms will
               be crucial in developing novel therapeutics to treat those with advanced prostate cancer.



               CONCLUSION
               Overall, lncRNAs play a multifaceted role in controlling the ncRNA network, which is vitally important
               throughout embryogenesis and vertebrate development. Here we discussed the ways in which lncRNAs can
               function as metastatic regulators, primarily by controlling epigenetic mechanisms, such as the recruitment
               of co-repressor complexes including PRC1/2, as well as co-transcriptional complexes such as CREB/REST to
               specific chromatin regions. Therefore, lncRNAs represent a unique class of ncRNA that operate as scaffolds
               to bring specific chromosomal foci into proximity with epigenetic regulators and chromatin modifiers.
               lncRNAs also control the appropriate expression of the DNA methylation machinery such as DNMT1,
               and function as competitive binding partners for other ncRNAs with complementary sequences. As such,
               lncRNAs serve as potent disruptors of conserved RNA-RNA regulatory networks.

               Interestingly, lncRNA sequences are not highly conserved across species, however lncRNAs harbor a
               conserved positional synteny that is linked with the regulatory function of that specific lncRNA. This presents
               a unique challenge for the lncRNA field in that determining the importance of a lncRNA molecule found to
               be differently expressed under certain experimental conditions cannot be further studied by assessing the
               conservation of the sequence. Investigators will require a more nuanced approach in studying the landscape
               of the surrounding genomic architecture, the proximity of certain DNA response elements, and if specific
               protein coding genes flank the lncRNA, while also keeping in mind the state of the surrounding chromatin
               architecture and determining if the DNA region is highly hetero- or eu-chromatinized [Figure 2C].
   255   256   257   258   259   260   261   262   263   264   265